https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46765 Wed 24 Apr 2024 10:05:04 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11474 Wed 11 Apr 2018 16:53:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6937 Wed 11 Apr 2018 15:48:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9218 65 years of age) drivers (pooled OR 1.13; 95% CI 0.97, 1.31) than in drivers <65 years of age (pooled OR 2.21; 95% CI 1.31, 3.73), a result consistent with age-stratified risk differences reported in cohort studies. Anxiolytics, taken in single or multiple doses during the daytime, impaired driving performance independent of their half-lives. With hypnotics, converging evidence from experimental and epidemiological studies indicates that diazepam, flurazepam, flunitrazepam, nitrazepam and the short half-life non-benzodiazepine hypnotic zopiclone significantly impair driving, at least during the first 2–4 weeks of treatment. The accident risk was higher in the elderly (>65 years of age) who use tricyclic antidepressants (TCAs); however, the evidence for an association of antidepressants with accident risk in younger drivers was equivocal. Sedative but not non-sedative antidepressants were found to cause short-term impairment of several measures of driving performance. Limited epidemiological research reported that opioids may be associated with increased accident risk in the first few weeks of treatment. Conclusions: Benzodiazepine use was associated with a significant increase in the risk of traffic accidents and responsibility of drivers for accidents. The association was more pronounced in the younger drivers. The accident risk was markedly increased by co-ingestion of alcohol. Driving impairment was generally related to plasma half-lives of hypnotics, but with notable exceptions. Anxiolytics, with daytime dosing, impaired driving independent of their half-lives. TCAs appeared to be associated with increased accident risk, at least in the elderly, and caused short-term impairment in driving performance. Opioid users may be at a higher risk of traffic accidents; however, experimental evidence is limited on their effects on driving.]]> Wed 11 Apr 2018 14:30:29 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9557 Wed 11 Apr 2018 13:57:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8456 Wed 11 Apr 2018 13:48:59 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11541 Wed 11 Apr 2018 13:32:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6944 96%; kappa, >0.92) and the news sources of each target story (interrater agreement, >94%; kappa, >0.91). National rankings of the top 200 US newspapers by audited circulation were used to quantify the extent of coverage as the proportion of the total circulation of ranked newspapers in Newseum. Findings: In total, 1630 front pages were searched. Each medical story appeared on the front pages of 85 to 117 (67.5%-78.7%) ranked newspaper titles that had a cumulative daily circulation of 23.1 to 33.4 million, or 61.8% to 88.4% of all newspapers. In contrast, the non-medical story achieved front-page coverage in 152 (99.3%) newspaper titles with a total circulation of 41.0 million, or 99.8% of all newspapers. Front-page medical stories varied in their sources, but the Washington Post, Los Angeles Times, New York Times and the Associated Press together supplied 61.7% of the total coverage of target front-page medical stories. Conclusion: Front-page coverage of medical news from different sources is more accurately revealed by analysis of circulation counts rather than of newspaper titles. Journals wishing to widen knowledge of research news and organizations with important health announcements should target at least the four dominant media organizations identified in this study.]]> Wed 11 Apr 2018 13:16:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20857 Wed 11 Apr 2018 11:55:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7014 Sat 24 Mar 2018 08:38:04 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8503 Sat 24 Mar 2018 08:36:25 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10955 Sat 24 Mar 2018 08:14:14 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10727 Sat 24 Mar 2018 08:09:49 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46640 Mon 28 Nov 2022 16:47:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47952 Mon 13 Feb 2023 14:00:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36056 Mon 03 Feb 2020 11:52:08 AEDT ]]>